Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
Stride, Inc. (LRN)
NYSEConsumer DiscretionaryEducation & Training ServicesSnapshot 2026-11-04
$74.87-5.51%
Close 2026-11-05 · 1-day change
NYSEConsumer DiscretionaryEducation & Training ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
7.93 → 8.24 EPS · FY ending Jun 30, 2028 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for LRN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS about $8.1 per share in fiscal 2026 | A supporting condition in Stride, Inc.'s published investment case. The stated target is ≈$8.1 per share. | Intact | EPS falls below $7.5 per share in FY26 | Diluted EPS: $1.45 per share FY2027-Q1; GAAP. Published target: ≈$8.1 per share. Annual target cannot be compared with a quarterly or TTM observation. Oct 21, 20261.45 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
LRN is a growth-oriented education business with mixed execution, rather than a clearly durable compounder. Its long-term thesis has weakened this month, even as total risk has declined and recent results included an earnings beat.
LRN is described as cheap versus peers, while the valuation evidence also shows a peer premium and an expectations gap, so the signals are mixed. The priced-in assessment is tagged justified, with low fragility; the evidence does not indicate that the market assumes either exceptionally strong or broadly fragile execution.
Near term, revenue growth and Career Learning delivery are positive, but gross profit and first-quarter adjusted operating income were below the year-earlier levels. The investment in curriculum, technology, and support services has yet to show clear progress in gross profit, and recent financial performance has slipped relative to the industry. Risk is elevated, though it has fallen from high, and a guidance cut would be a meaningful negative.
Over the next few quarters, the thesis hinges on whether Career Learning growth continues and management turns its investments into stronger financial progress. Guidance is a key swing factor: a cut would weaken the case, while continued earnings strength from sector bellwethers LAUR, CVSA, and LOPE could support the sector backdrop. Misses or lower guidance from those peers could remove that support.
For the next 1 to 3 years, LRN has real growth evidence, but fragile earnings quality and weaker recent industry standing make execution the central issue. The current evidence supports a cautious, mixed long-term thesis. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Profit stays near $495 million. |
| Broken |
| Operating income falls below $130 million in any quarter |
Operating income: $84.268M FY2027-Q1; GAAP. Published target: ≈$495 million. Annual target cannot be compared with a quarterly or TTM observation. Oct 21, 202684,268,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to about $2.495 billion in fiscal 2026 | Stride grows revenue about 3% yearly to $2.5 billion in 2026. | Intact | Revenue falls below $2.37 billion in FY26 | Revenue: $639.378M FY2027-Q1; GAAP. Published target: ≈$2.495 billion. Annual target cannot be compared with a quarterly or TTM observation. Oct 21, 2026639,378,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$8.09 → $8.24 · observed estimates
$2.75B → $2.66B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-07-25 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-07-26 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-07-27 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-07-28 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-07-29 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-07-30 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-07-31 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-08-01 | $8.09 | $2,751,600,000 | 1 / 1 |
| 2026-08-02 | $8.09 | $2,733,566,700 | 1 / 1 |
| 2026-08-03 | $8.09 | $2,733,566,700 | 1 / 1 |
| 2026-08-04 | $8.09 | $2,733,566,700 | 1 / 1 |
| 2026-08-05 | $8.09 | $2,733,566,700 | 1 / 1 |
| 2026-08-06 | $8.09 | $2,733,566,700 | 1 / 1 |
| 2026-08-07 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-08 | $9.28 | $2,684,133,330 | 3 / 3 |
| 2026-08-09 | $9.28 | $2,684,133,330 | 3 / 3 |
| 2026-08-10 | $9.28 | $2,684,133,330 | 3 / 3 |
| 2026-08-12 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-13 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-14 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-15 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-16 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-17 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-18 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-19 | $7.93 | $2,684,133,333 | 2 / 2 |
| 2026-08-20 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-21 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-22 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-23 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-24 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-25 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-26 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-27 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-28 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-29 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-30 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-08-31 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-01 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-02 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-03 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-04 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-05 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-06 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-07 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-08 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-09 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-10 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-11 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-12 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-13 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-14 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-15 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-16 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-17 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-18 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-19 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-20 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-21 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-22 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-23 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-24 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-25 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-26 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-27 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-28 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-29 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-09-30 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-10-01 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-10-02 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-10-03 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-10-04 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-10-05 | $7.93 | $2,643,925,000 | 3 / 3 |
| 2026-10-06 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-07 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-08 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-09 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-10 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-11 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-12 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-13 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-14 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-15 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-16 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-17 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-18 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-19 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-20 | $7.93 | $2,643,925,000 | 2 / 2 |
| 2026-10-21 | $8.08 | $2,647,075,000 | 2 / 2 |
| 2026-10-22 | $8.08 | $2,647,075,000 | 2 / 2 |
| 2026-10-23 | $8.08 | $2,647,075,000 | 3 / 3 |
| 2026-10-24 | $8.24 | $2,648,325,000 | 3 / 3 |
| 2026-10-25 | $8.24 | $2,648,325,000 | 3 / 3 |
| 2026-10-26 | $8.24 | $2,648,325,000 | 3 / 3 |
| 2026-10-27 | $8.24 | $2,648,325,000 | 3 / 3 |
| 2026-10-28 | $8.24 | $2,661,058,500 | 3 / 3 |
| 2026-10-29 | $8.24 | $2,661,058,500 | 3 / 3 |
| 2026-10-30 | $8.24 | $2,661,058,500 | 3 / 3 |
| 2026-10-31 | $8.24 | $2,661,058,500 | 3 / 3 |
| 2026-11-01 | $8.24 | $2,661,058,500 | 3 / 3 |
| 2026-11-02 | $8.24 | $2,661,058,500 | 3 / 3 |
| 2026-11-03 | $8.24 | $2,661,058,500 | 3 / 3 |
| 2026-11-04 | $8.24 | $2,661,058,500 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.